Ask a Doctor is new series of physician-authored columns offering insights and advice on common health topics. It is not a ...

Sucralose increases hypothalamic activity linked to hunger more than sugar or water, especially in women and people with ...

The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...

Plastic surgeons are reporting a surge in patients demanding 'dangerous' cosmetic operations due to the effects of losing a ...

Novo Nordisk has experienced a 50% drop due to potential tariffs and recent clinical trial results. Read why I rate NVO stock a strong buy right now.

There’s no denying that GLP-1 medications like Ozempic and Wegovy are having a moment. You’ve probably seen the headlines, ...

Glucofreedom, is FDA-approved and fulfills GMP quality as per required healthrequirements, making it top selling product in ...

While it can affect your body differently when you have diabetes, sugar doesn’t have to be completely off the table.

Findings from the American College of Cardiology 2025 Annual Scientific Session show oral semaglutide reduces the risk of heart attack, stroke, and cardiovascular death by 14% in patients with type 2 ...